ResMed | RMD - Operating Expenses


ResMed reported $925.74M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Ansell USD 880.1M 465.65M Dec/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 140.72M 2.71M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Cochlear AUD 914.9M 454.8M Dec/2025
Cooper Companies USD 1.11B 301.2M Mar/2026
CSL USD 5.7B 2.82B Dec/2025
Dexcom USD 936.6M 0 Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Fisher Paykel Healthcare NZD 802.4M 24.1M Dec/2025
Globus Medical USD 595.85M 49.26M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
Idexx Laboratories USD 778.23M 3.26M Mar/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Philips EUR 3.6B 775M Mar/2026
Ramsay Health Care AUD 8.8B 83.5M Dec/2025
ResMed USD 925.74M 525K Mar/2026
Sigma Healthcare AUD 1.68B 174.89M Dec/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Steris USD 1.27B 51.5M Mar/2026
Teleflex USD 3.08B 2.55B Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026